Envoy Medical Statistics

Total Valuation

Envoy Medical has a market cap or net worth of $29.43 million. The enterprise value is $43.61 million.

Market Cap	29.43M
Enterprise Value	43.61M

Important Dates

The next estimated earnings date is Wednesday, May 14, 2025, after market close.

Earnings Date	May 14, 2025
Ex-Dividend Date	n/a

Share Statistics

Envoy Medical has 21.33 million shares outstanding. The number of shares has increased by 52.83% in one year.

Current Share Class	21.33M
Shares Outstanding	21.33M
Shares Change (YoY)	+52.83%
Shares Change (QoQ)	-16.67%
Owned by Insiders (%)	37.83%
Owned by Institutions (%)	14.13%
Float	10.73M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	115.25
Forward PS	82.44
PB Ratio	-1.56
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	193.82
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.24

Current Ratio	1.24
Quick Ratio	0.84
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-23.60

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-121.51%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-481.40%
Revenue Per Employee	$5,357
Profits Per Employee	-$666,024
Employee Count	42
Asset Turnover	0.02
Inventory Turnover	0.48

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -67.41% in the last 52 weeks. The beta is 2.33, so Envoy Medical's price volatility has been higher than the market average.

Beta (5Y)	2.33
52-Week Price Change	-67.41%
50-Day Moving Average	1.38
200-Day Moving Average	2.07
Relative Strength Index (RSI)	49.62
Average Volume (20 Days)	13,592

Short Selling Information

The latest short interest is 95,964, so 0.45% of the outstanding shares have been sold short.

Short Interest	95,964
Short Previous Month	107,406
Short % of Shares Out	0.45%
Short % of Float	0.89%
Short Ratio (days to cover)	5.90

Income Statement

In the last 12 months, Envoy Medical had revenue of $225,000 and -$27.97 million in losses. Loss per share was -$1.49.

Revenue	225,000
Gross Profit	-517,000
Operating Income	-19.26M
Pretax Income	-23.04M
Net Income	-27.97M
EBITDA	-19.08M
EBIT	-19.26M
Loss Per Share	-$1.49

Full Income Statement

Balance Sheet

The company has $5.48 million in cash and $19.66 million in debt, giving a net cash position of -$14.18 million or -$0.66 per share.

Cash & Cash Equivalents	5.48M
Total Debt	19.66M
Net Cash	-14.18M
Net Cash Per Share	-$0.66
Equity (Book Value)	-18.84M
Book Value Per Share	-0.88
Working Capital	1.85M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$17.95 million and capital expenditures -$980,000, giving a free cash flow of -$18.93 million.

Operating Cash Flow	-17.95M
Capital Expenditures	-980,000
Free Cash Flow	-18.93M
FCF Per Share	-$0.89

Full Cash Flow Statement

Margins

Gross Margin	-229.78%
Operating Margin	-8,558.22%
Pretax Margin	-9,242.22%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Envoy Medical does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-52.83%
Shareholder Yield	-52.83%
Earnings Yield	-95.05%
FCF Yield	-64.32%

Analyst Forecast

The average price target for Envoy Medical is $9.13, which is 559.21% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$9.13
Price Target Difference	559.21%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Envoy Medical has an Altman Z-Score of -38.72 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-38.72
Piotroski F-Score	2